Soren Acquisition Corp. Warrants 2026-14.11.32 On Soren Acqn
SORNW
NASDAQ Global Market0.25
USD
+0.00
- -
CIK
0002086263
ISIN
KYG8274J1114
CUSIP
G8274J111
Return %
Stock
S&P500
1Y
-46.38
15.98
3Y
-46.38
62.25
5Y
-46.38
67.55
Capital Structure
FRC
•
in mil. unless spec.Working Capital
FRC
•
in mil. unless spec.Growth Rates
FRC
•
in mil. unless spec.Quarterly Revenue
FRC
•
in mil. unless spec.Quarterly Earnings Per Share
FRC
•
in mil. unless spec.Quarterly Dividends Per Share
FRC
•
in mil. unless spec.- CEO
- Arghavan Di Rezze
- Full Time Employees
- 2
- Sector
- Financial Services
- Industry
- Financial - Conglomerates
- Address
- 1000 Brickell Avenue Miami FL United States of America 33131
- IPO Date
- Feb 27, 2026
- CIK
- 0002086263
- Website
- sorenacquisition.com
- Similar Companies
- Business
- Soren Acquisition Corp. is a blank-check company formed to effect a merger, amalgamation, share exchange, asset acquisition, or similar business combination with one or more enterprises, with a focus on opportunities in the healthcare sector; it operates primarily as a special purpose acquisition company (SPAC) located in the United States, with headquarters in Miami, Florida, and was founded in 2025. The company files and discloses findings related to its business combinations, securities, and strategic developments through standard SPAC channels and government filings. Main products and services - Special purpose acquisition company (SPAC) platform: formation, governance, and pursuit of a business combination; securities issuance and trading through units comprising Class A ordinary shares and warrants; management and sponsor alignment and oversight. - Targeting and deal origination: sourcing, evaluating, and negotiating merger, acquisition, or business combination opportunities; due diligence coordination; structuring of transaction terms; coordination with a board and advisors. - Financing and liquidity solutions: initial public offering (IPO) activities and subsequent capital deployment; warrant structuring and separate trading mechanics; capital raising and underwriting relationships. - Post-transaction value creation: integration support and strategic oversight post-merger; monitoring of operational milestones and governance alignment; positioning for regulatory approvals and seamless transition. Latest major company changes - Separate trading of Class A ordinary shares and warrants to provide distinct liquidity and trading dynamics, with warrants exercisable at a defined price; this separation occurred in February 2026 and introduces ticker differentiation for the warrants (SORNW) and shares (SORN) [web results indicate February 27, 2026 start of separate trading]. - Closure of its initial public offering, raising approximately $253 million in gross proceeds from the sale of 25,300,000 units (including over-allotment units exercised), marking the completion of its IPO as of January 8, 2026. - Ongoing activities around deal sourcing and structuring as part of its SPAC lifecycle, with public disclosures on units trading dynamics and potential future business combinations across target sectors, notably healthcare. Additional context - Industry and segments: SPAC/financial services vehicle designed to merge with or acquire operating companies, with a stated focus on healthcare targets; involves investment management, corporate financing, and deal execution services. - Target markets and customers: public market investors seeking SPAC exposure and potential target companies in the healthcare sector pursuing a public listing via merger; sponsors and underwriters involved in IPO and liquidation mechanics. - Geographic operations: United States-based SPAC with headquarters in the United States; listings and trading are US-regulated, with liquidity events in US markets. - Founding year and headquarters: founded in 2025; headquarters located in Miami, Florida, United States. - Subsidiaries/parent relationships: as a SPAC, Soren Acquisition Corp. operates as a standalone vehicle aligned with its sponsor and executive team, with no explicit parent company disclosed beyond its SPAC structure; board and advisory support from named individuals. Notes - Core focus remains on identifying and executing a strategic business combination, primarily within healthcare, while offering investors exposure to a SPAC vehicle through its Class A shares and warrants; latest notable developments include the separate trading of shares and warrants and the IPO closing. The information reflects publicly disclosed corporate actions and typical SPAC lifecycle milestones.